Abstract
The psychostimulant medications methylphenidate (MPH) and amphetamine (AMP), available in various ratios or enantiopure formulations of their respective active dextrorotary isomers, constitute the majority of agents used in the treatment of attention-deficit/hyperactivity disorder (ADHD). Substantial interindividual variability occurs in their pharmacokinetics and tolerability. Little is known regarding the potential role of drug transporters such as P-glycoprotein (P-gp) in psychostimulant pharmacokinetics and response. Therefore, experiments were carried out in P-gp knockout (KO) mice versus wild-type (WT) mice after intraperitoneal dosing (2.5 mg/kg) of d-MPH or (3.0 mg/kg) of d-AMP. After the administration of each psychostimulant, locomotor activity was assessed at 30-min intervals for 2 h. Total brain-to-plasma drug concentration ratios were determined at 10-, 30-, and 80-min postdosing time-points. The results showed no statistically supported genotypic difference in d-AMP-induced locomotor activity stimulation or in brain-to-plasma ratio of d-AMP. As for d-MPH, the P-gp KO mice had 33% higher brain concentrations (p < 0.05) and 67.5% higher brain-to-plasma ratios (p < 0.01) than WT controls at the 10-min postdosing time...Continue Reading
References
Nov 28, 1997·Brain Research·H MannJ L Cadet
May 7, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·L L GreenhillH Abikoff
May 20, 1999·Annual Review of Pharmacology and Toxicology·S V AmbudkarM M Gottesman
Jul 9, 1999·The Analyst·O al-DirbashiK Nakashima
May 10, 2000·Journal of the American Academy of Child and Adolescent Psychiatry·S R PliszkaS K Wynne
Jun 6, 2000·Advanced Drug Delivery Reviews·A H Schinkel
Jul 13, 2000·Journal of the American Academy of Child and Adolescent Psychiatry·S R PliszkaM G Toprac
Oct 3, 2001·Pediatrics·UNKNOWN American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvemen
Feb 9, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Laurence L GreenhillUNKNOWN American Academy of Child and Adolescent Psychiatry
Sep 28, 2002·Journal of Clinical Psychopharmacology·Stephen V FaraoneChristine Roe
Dec 20, 2002·Clinical Pharmacokinetics·Jiunn H Lin, Masayo Yamazaki
Jan 22, 2003·Advanced Drug Delivery Reviews·Jiunn H Lin
Apr 18, 2003·Journal of Medicinal Chemistry·Dietmar SchwabJörg Huwyler
Jan 1, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jun-Sheng WangC Lindsay De Vane
Jan 9, 2004·Psychopharmacology·Jun-Sheng WangC Lindsay DeVane
Mar 6, 2004·Pharmacology·Gert Fricker, David S Miller
May 6, 2004·Cancer Research·Salvatore CisterninoJean-Michel Scherrmann
Sep 14, 2004·Pharmaceutical Research·Gloria Lee, Reina Bendayan
Oct 27, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Angela DoranChenghong Zhang
Mar 15, 2005·Toxicology Letters·David BalayssacFrançois Coudore
Jul 14, 2005·Progress in Neurobiology·Wolfgang Löscher, Heidrun Potschka
Jul 19, 2005·Lancet·Joseph Biederman, Stephen V Faraone
Sep 13, 2005·Clinical Pharmacology and Therapeutics·Richard H Ho, Richard B Kim
Nov 22, 2005·Expert Opinion on Drug Delivery·Kennerly S PatrickJohn S Markowitz
Citations
Mar 13, 2008·Environmental Health Perspectives·J Leigh LeasureDonald A Fox
Mar 5, 2011·Biological & Pharmaceutical Bulletin·Jillissa Christine MolnariAlan Lewis Myers
Jul 22, 2008·European Journal of Pharmacology·Andrew Crowe, Susanna Diep
Oct 30, 2007·European Journal of Pharmacology·Hao-Jie ZhuJohn S Markowitz
May 9, 2014·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Estela Maria BruxelLuis Augusto Rohde
Apr 21, 2010·Journal of Neurochemistry·Hao-Jie ZhuJohn S Markowitz
Jan 21, 2014·Neuropharmacology·Joana GonçalvesAna Paula Silva
Nov 6, 2009·The International Journal of Neuropsychopharmacology·Nicolas TournierXavier Declèves
Feb 2, 2008·Biological & Pharmaceutical Bulletin·Jun-Sheng WangCarl Lindsay DeVane
Jan 16, 2007·Behavioural Pharmacology·Robin L WilliardKennerly S Patrick
Apr 6, 2019·Pharmacogenetics and Genomics·Tyler StevensTeri E Klein
Nov 2, 2019·Journal of Child and Adolescent Psychopharmacology·Hajra MazharPhilippe Robaey
Jun 19, 2013·Journal of Clinical Psychopharmacology·So Won KimKi-Hwan Yook
Sep 15, 2017·Journal of Child and Adolescent Psychopharmacology·John S Markowitz, Kennerly S Patrick